Helou Consulting provides medical and operational expertise in drug development.

COVID-19 Scientific & Management Service.


We have extensive expertise in supporting small, medium and large companies in drug development in all major therapeutic areas with special focus on anti-infectives.

Our customized support on medical and operational aspects ensures optimization of regulatory times and scientifically sound strategies.

We have a proven track record of having designed research programs and supported the execution of clinical trials from concept to publication.

Silvia Helou, MD, MMSc | Founder & Executive Consultant

Silvia has extensive drug development experience in major therapeutic areas including anti-infectives, dermatology, oncology/hematology, and immunology/biologics.

She previously held various senior positions at Novartis, Schering-Plough and Scynexis in clinical development. She was also responsible for several development programs in anti-infectives, non-malignant hematologic disease, oncology and dermatology. She obtained her medical degree at the University of Buenos Aires, Argentina, and her post-graduate degree in infectious disease with board certification (infectious disease & Mycology).

She served as staff faculty in infectious disease at the Muniz Infectious disease hospital and faculty in microbiology at the University of Buenos Aires, School of Medicine in Buenos Aires, Argentina.

Author & Co-Author of multiple scientific publications and presentations at international scientific meetings.

New Jersey

100 Warren St., unit. 1205

Jersey City, NJ 07302

+1 (732) 725 7692